659 related articles for article (PubMed ID: 24661247)
41. Analysis of diffusion tensor imaging metrics for gliomas grading at 3 T.
Server A; Graff BA; Josefsen R; Orheim TE; Schellhorn T; Nordhøy W; Nakstad PH
Eur J Radiol; 2014 Mar; 83(3):e156-65. PubMed ID: 24457139
[TBL] [Abstract][Full Text] [Related]
42. Intravoxel incoherent motion diffusion-weighted MR imaging of gliomas: efficacy in preoperative grading.
Hu YC; Yan LF; Wu L; Du P; Chen BY; Wang L; Wang SM; Han Y; Tian Q; Yu Y; Xu TY; Wang W; Cui GB
Sci Rep; 2014 Dec; 4():7208. PubMed ID: 25434593
[TBL] [Abstract][Full Text] [Related]
43. Uterine tumors: comparison of 3D versus 2D T2-weighted turbo spin-echo MR imaging at 3.0 T--initial experience.
Hori M; Kim T; Onishi H; Ueguchi T; Tatsumi M; Nakamoto A; Tsuboyama T; Tomoda K; Tomiyama N
Radiology; 2011 Jan; 258(1):154-63. PubMed ID: 21045182
[TBL] [Abstract][Full Text] [Related]
44. Distinguishing tumefactive demyelinating lesions from glioma or central nervous system lymphoma: added value of unenhanced CT compared with conventional contrast-enhanced MR imaging.
Kim DS; Na DG; Kim KH; Kim JH; Kim E; Yun BL; Chang KH
Radiology; 2009 May; 251(2):467-75. PubMed ID: 19261924
[TBL] [Abstract][Full Text] [Related]
45. Three-dimensional dynamic susceptibility-weighted perfusion MR imaging at 3.0 T: feasibility and contrast agent dose.
Manka C; Träber F; Gieseke J; Schild HH; Kuhl CK
Radiology; 2005 Mar; 234(3):869-77. PubMed ID: 15665227
[TBL] [Abstract][Full Text] [Related]
46. In the assessment of supratentorial glioma grade: the combined role of multivoxel proton MR spectroscopy and diffusion tensor imaging.
Zou QG; Xu HB; Liu F; Guo W; Kong XC; Wu Y
Clin Radiol; 2011 Oct; 66(10):953-60. PubMed ID: 21663899
[TBL] [Abstract][Full Text] [Related]
47. Comparison of permeability in high-grade and low-grade brain tumors using dynamic susceptibility contrast MR imaging.
Provenzale JM; Wang GR; Brenner T; Petrella JR; Sorensen AG
AJR Am J Roentgenol; 2002 Mar; 178(3):711-6. PubMed ID: 11856703
[TBL] [Abstract][Full Text] [Related]
48. Diffusion-weighted MR of the brain: methodology and clinical application.
Mascalchi M; Filippi M; Floris R; Fonda C; Gasparotti R; Villari N
Radiol Med; 2005 Mar; 109(3):155-97. PubMed ID: 15775887
[TBL] [Abstract][Full Text] [Related]
49. Added value of diffusion-weighted MR imaging in the diagnosis of ampullary carcinoma.
Jang KM; Kim SH; Lee SJ; Park HJ; Choi D; Hwang J
Radiology; 2013 Feb; 266(2):491-501. PubMed ID: 23238154
[TBL] [Abstract][Full Text] [Related]
50. Validation of quantitative analysis of multiparametric prostate MR images for prostate cancer detection and aggressiveness assessment: a cross-imager study.
Peng Y; Jiang Y; Antic T; Giger ML; Eggener SE; Oto A
Radiology; 2014 May; 271(2):461-71. PubMed ID: 24533870
[TBL] [Abstract][Full Text] [Related]
51. Differentiation of malignant from benign pheochromocytomas with diffusion-weighted and dynamic contrast-enhanced magnetic resonance at 3.0 T.
Dong Y; Liu Q
J Comput Assist Tomogr; 2012; 36(4):361-6. PubMed ID: 22805661
[TBL] [Abstract][Full Text] [Related]
52. Chronic tibiofibular syndesmosis injury of ankle: evaluation with contrast-enhanced fat-suppressed 3D fast spoiled gradient-recalled acquisition in the steady state MR imaging.
Kim S; Huh YM; Song HT; Lee SA; Lee JW; Lee JE; Chung IH; Suh JS
Radiology; 2007 Jan; 242(1):225-35. PubMed ID: 17185669
[TBL] [Abstract][Full Text] [Related]
53. Detection of prostate cancer with magnetic resonance imaging: optimization of T1-weighted, T2-weighted, dynamic-enhanced T1-weighted, diffusion-weighted imaging apparent diffusion coefficient mapping sequences and MR spectroscopy, correlated with biopsy and histopathological findings.
Aydin H; Kizilgöz V; Tatar IG; Damar C; Ugan AR; Paker I; Hekimoğlu B
J Comput Assist Tomogr; 2012; 36(1):30-45. PubMed ID: 22261768
[TBL] [Abstract][Full Text] [Related]
54. Perfusion, diffusion and spectroscopy values in newly diagnosed cerebral gliomas.
Catalaa I; Henry R; Dillon WP; Graves EE; McKnight TR; Lu Y; Vigneron DB; Nelson SJ
NMR Biomed; 2006 Jun; 19(4):463-75. PubMed ID: 16763973
[TBL] [Abstract][Full Text] [Related]
55. Posttreatment recurrence of malignant brain neoplasm: accuracy of relative cerebral blood volume fraction in discriminating low from high malignant histologic volume fraction.
Gasparetto EL; Pawlak MA; Patel SH; Huse J; Woo JH; Krejza J; Rosenfeld MR; O'Rourke DM; Lustig R; Melhem ER; Wolf RL
Radiology; 2009 Mar; 250(3):887-96. PubMed ID: 19244052
[TBL] [Abstract][Full Text] [Related]
56. Prostate cancer: computer-aided diagnosis with multiparametric 3-T MR imaging--effect on observer performance.
Hambrock T; Vos PC; Hulsbergen-van de Kaa CA; Barentsz JO; Huisman HJ
Radiology; 2013 Feb; 266(2):521-30. PubMed ID: 23204542
[TBL] [Abstract][Full Text] [Related]
57. Renal masses: quantitative analysis of enhancement with signal intensity measurements versus qualitative analysis of enhancement with image subtraction for diagnosing malignancy at MR imaging.
Hecht EM; Israel GM; Krinsky GA; Hahn WY; Kim DC; Belitskaya-Levy I; Lee VS
Radiology; 2004 Aug; 232(2):373-8. PubMed ID: 15215544
[TBL] [Abstract][Full Text] [Related]
58. Areas suspicious for prostate cancer: MR-guided biopsy in patients with at least one transrectal US-guided biopsy with a negative finding--multiparametric MR imaging for detection and biopsy planning.
Franiel T; Stephan C; Erbersdobler A; Dietz E; Maxeiner A; Hell N; Huppertz A; Miller K; Strecker R; Hamm B
Radiology; 2011 Apr; 259(1):162-72. PubMed ID: 21233291
[TBL] [Abstract][Full Text] [Related]
59. Multiparametric Magnetic Resonance Imaging for Discriminating Low-Grade From High-Grade Prostate Cancer.
Vos EK; Kobus T; Litjens GJ; Hambrock T; Hulsbergen-van de Kaa CA; Barentsz JO; Maas MC; Scheenen TW
Invest Radiol; 2015 Aug; 50(8):490-7. PubMed ID: 25867656
[TBL] [Abstract][Full Text] [Related]
60. Utility of multiparametric 3-T MRI for glioma characterization.
Roy B; Gupta RK; Maudsley AA; Awasthi R; Sheriff S; Gu M; Husain N; Mohakud S; Behari S; Pandey CM; Rathore RK; Spielman DM; Alger JR
Neuroradiology; 2013 May; 55(5):603-13. PubMed ID: 23377234
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]